
Lenalidomide Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules
Available Strengths: 2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg
Reference Brands: Revlimid® (EU & US)
Category: Oncology Cancer Care
Lenalidomide is available in Oral Capsules and strengths such as 2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lenalidomide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lenalidomide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Lenalidomide is an immunomodulatory drug (IMiD) used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). Available under the brand Revlimid® by Bristol Myers Squibb, it is offered in oral capsule form in strengths ranging from 2.5 mg to 25 mg. Lenalidomide works by enhancing the immune system and inhibiting tumor cell growth. Widely sourced by B2B pharmaceutical wholesalers in the US and EU, it ensures reliable supply of high-quality, GMP-compliant medications for oncology centers, providing competitive pricing for cancer treatments.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers